Abstract
The objective of this study was to evaluate the impact of digital ulcers (DUs) in daily life of systemic sclerosis (SSc) Spanish patients. We developed a multicenter observational study to compare functional disability in SSc patients with active DUs vs. those without DUs. An additional correlation between perception of patients and physicians on disability due to DUs was performed. A total of 199 patients were enrolled, 70 (35%) with DUs. Patients with DUs were younger (48 vs. 58 years; p < 0.001) and had more frequently the diffuse subtype of SSc (45 vs. 24%; p = 0.004) than patients without DUs. Patients with DUs showed significantly higher scores in the Cochin Hand Function Scale overall (p < 0.002) and for each of its five dimensions. They also showed higher scores in the Systemic Sclerosis Health Assessment Questionnaire items related to hand function such as, dress and self-care (p < 0.013), eat (p < 0.013) and grip (p < 0.03), and higher Visual Analogic Scale scores for pain (p < 0.013), trouble related with Raynaud’s Phenomenon (p < 0.001) and sense of severity (p < 0.004). Impact on daily activities was significantly higher in patients with DUs (p = 0.002), with a non-significant trend to experience higher impact on work productivity (p = 0.07). A high correlation was found between DUs patients and physicians opinion on the impact of DUs (daily life: Pearson R = 0.86; work productivity: Pearson R = 0.87). Study findings show an impaired hand function and increased disability for daily life activities and work productivity in SSc patients with DUs compared with patients without DUs in Spanish population.
Similar content being viewed by others
References
Flavahan NA, Flavahan S, Mitra S, Chotani MA (2003) The vasculopathy of Raynaud’s phenomenon and scleroderma. Rheum Dis Clin North Am 29(2):275–291
Steen V, Denton CP, Pope JE, Matucci-Cerinic M (2009) Digital ulcers: overt vascular disease in systemic sclerosis. Rheumatology 48(Suppl 3):19–24
Schiopu E, Impens AJ, Phillips K (2010) Digital ischemia in scleroderma spectrum of diseases. Int J Rheumatol. https://doi.org/10.1155/2010/923743
Ingraham KM, Steen VD (2006) Morbidity of digital tip ulcerations in scleroderma. Arthritis Rheum 54(Suppl 9):P578
Denton CP, Korn JH (2003) Digital ulceration and critical digital ischemia in scleroderma. Sleroderma Care Res 1(1):12–16
Mouthon L, Mestre-Stanislas C, Bérezné A, Rannou F, Guilpain P, Revel M et al (2010) Impact of digital ulcers on disability and health-related quality of life in systemic sclerosis. Ann Rheum Dis 69(1):214–217
Maddali-Bongi S, Del Rosso A, Mikhaylova S, Francini B, Branchi A, Baccini M et al (2014) Impact of hand and face disabilities on global disability and quality of life in systemic sclerosis patients. Clin Exp Rheumatol 32(6 Suppl 86):15–20
Nihtyanova SI, Brough GM, Black CM, Denton CP (2008) Clinical burden of digital vasculopathy in limited and diffuse cutaneous systemic sclerosis. Ann Rheum Dis 67(1):120–123
Korn JH, Mayes M, Matucci Cerinic M, Rainisio M, Pope J, Hachulla E et al (2004) Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist. Arthritis Rheum 50(12):3985–3993
Schouffoer AA, Schoones JW, Terwee CB, Vliet Vlieland TPM (2012) Work status and its determinants among patients with systemic sclerosis: a systematic review. Rheumatology 51(7):1304–1314
World Medical Association (2013) World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 310(20):2191–2194
LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15(2):202–205
Rannou F, Poiraudeau S, Berezné A, Baubet T, Le-Guern V, Cabane J et al (2007) Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin Hand Function Scale, health assessment questionnaire (HAQ), systemic sclerosis HAQ, and medical outcomes study 36-item short form health survey. Arthritis Rheum 57(1):94–102
Reilly MC, Zbrozek AS, Dukes EM (1993) The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics 4(5):353–365
Merkel PA, Herlyn K, Martin RW, Anderson JJ, Mayes MD, Bell P et al (2002) Measuring disease activity and functional status in patients with scleroderma and Raynaud’s phenomenon. Arthritis Rheum 46(9):2410–2420
Johnson SR, Hawker GA, Davis AM (2005) The health assessment questionnaire disability index and scleroderma health assessment questionnaire in scleroderma trials: an evaluation of their measurement properties. Arthritis Rheum 53(2):256–262
Bérezné A, Seror R, Morell-Dubois S, de Menthon M, Fois E, Dzeing-Ella A et al (2011) Impact of systemic sclerosis on occupational and professional activity with attention to patients with digital ulcers. Arthritis Care Res 63(2):277–285
Decuman S, Smith V, Verhaeghe S, Deschepper E, Vermeiren F, De Keyser F (2012) Work participation and work transition in patients with systemic sclerosis: a cross-sectional study. Rheumatology 51(2):297–304
Mouthon L, Carpentier PH, Lok C, Clerson P, Gressin V, Hachulla E et al (2014) Ischemic digital ulcers affect hand disability and pain in systemic sclerosis. J Rheumatol 41(7):1317–1323
Georges C, Chassany O, Toledano C, Mouthon L, Tiev K, Meyer O et al (2006) Impact of pain in health related quality of life of patients with systemic sclerosis. Rheumatology 45(10):1298–1302
Hudson M, Impens A, Baron M, Seibold JR, Thombs BD, Walker JG et al (2010) Discordance between patient and physician assessments of disease severity in systemic sclerosis. J Rheumatol 37(11):2307–2312
Morrisroe K, Huq M, Stevens W, Sahhar J, Proudman S, Nikpour M (2016) Work productivity in systemic sclerosis and association with health related quality of life. Arthritis Rheumatol 68(Suppl 10):P2910
Poiraudeau S, Chevalier X, Conrozier T, Flippo RM, Lioté F, Noël E et al (2001) Reliability, validity, and sensitivity to change of the Cochin hand functional disability scale in hand osteoarthritis. Osteoarthr Cartil 9(6):570–577
Acknowledgements
The authors gratefully thank all contributing investigators and research teams of LAUDES study group: Dr. Aspe de la Iglesia, Bruno (Hospital de Meixoeiro, Vigo); Dra. Barbado Ajo, Julia (Hospital Clínico Universitario de Valladolid, Valladolid); Dr. Batista Perdomo, Daniel (Hospital Insular, Las Palmas de Gran Canaria); Dra. Beltrán Catalán, Emma (Hospital General Universitario de Valencia, Valencia); Dr. Belzunegui Otano, Joaquin (Hospital de Donostia, Donostia); Dr. Blanco Rodríguez, Jorge Santiago (Complejo Hospitalario Universitario de Santiago, Santiago de Compostela); Dr. Caamaño Freire, Manuel (Complejo Hospitalario Universitario de Santiago, Santiago de Compostela); Dr. Cantabrana Alútiz, Alberto (Hospital La Candelaria, Santa Cruz de Tenerife); Dra. Carrio Montes, Isabel (Hospital San Agustín, Avilés); Dra. Cia Lecumberri, Maite (Complejo Hospitalario de Navarra, Pamplona); Dra. Del Castillo Monsalvo, Rosa (Hospital de Guadalajara, Guadalajara); Dra. Diez Alvarez, Elvira (Hospital de León, León); Dr. Egües Dubuc, César Antonio (Hospital de Donostia, Donostia); Dra. Egurbide Arberas, Maria Victoria (Hospital de Cruces, Barakaldo); Dra. Fanlo Mateo, Patricia (Complejo Hospitalario de Navarra, Pamplona); Dra. Freire Dapena, Maria Del Carmen (Hospital Xeral Cies, Vigo); Dra. Freire González, Mercedes (Complejo Hospitalario Universitario de A Coruña, A Coruña); Dr. García Aparicio, Ángel (Hospital Virgen de la Salud, Toledo); Dr. García Hernández, Francisco José (Hospital Virgen del Rocío, Sevilla); Dr. Gómez de Salazar, José (Hospital La Vila, La Vila Joiosa); Dr. González Nieto, José Antonio (Hospital Can Misses, Eivissa); Dr. Graña Gil, Jenaro (Complejo Hospitalario Universitario de A Coruña, A Coruña); Dr. Guillén-Del-Castillo, Alfredo (Hospital Universitari Vall d’Hebron, Barcelona); Dr. Izquierdo Hidalgo, José (Hospital Santa Cristina, Madrid); Dr. Juan Mas, Toni (Hospital Son Llatzer, Palma); Dra. Laiño Piñeiro, Maria Cruz (Clínica Universitaria de Navarra, Pamplona); Dr. López Longo, Francisco Javier (Hospital Gregorio Marañón, Madrid); Dra. Lopez Núñez, Lilian Maria (Hospital del Mar, Barcelona); Dra. Marín Ballvé, Adela (Hospital Clínico Lozano Blesa, Zaragoza); Dr. Marras Fernandez-Cid, Carlos (Hospital Virgen de La Arrixaca, Murcia); Dr. Miguelez, Roberto (Hospital de Móstoles, Móstoles); Dr. Moran Rodriguez, Miguel Ángel (Hospital Universitario de Burgos, Burgos); Dr. Moreno Morales, Juan (Hospital Santa Lucía, Cartagena); Dra. Morlà, Rosa Maria (Hospital del Vendrell, El Vendrell); Dra. Ojeda Bruno, Soledad (Hospital Dr. Negrín, Las Palmas de Gran Canaria); Dr. Olivé Marqués, Alejandro (Hospital Germans Trias i Pujol, Badalona); Dr. Ornilla Laraundogoitia, Enrique (Clínica Universitaria de Navarra, Pamplona); Dr. Ortego, Noberto (Hospital San Cecilio, Granada); Dra. Ortiz Santamaria, Vera (Hospital General de Granollers, Granollers); Dra. Pérez Conesa, Mercedes Pilar (Hospital Miguel Servet, Zaragoza); Dra. Pérez Sandoval, Trinidad (Hospital de León, León); Dra. Pros Simon, Ana (Hospital del Mar, Barcelona); Dra. Rodríguez Lozano, Beatriz (Hospital Universitario de Canarias, Santa Cruz de Tenerife); Dra. Rueda Cid, Amalia (Hospital General de Valencia, Valencia); Dr. Sáez Comet, Luis (Hospital Miguel Servet, Zaragoza); Dr. Salvatierra Osorio, Juan (Hospital San Cecilio, Granada); Dr. Sanmartín López, Alejandro (Hospital de Elda, Elda); Dr. Santos Soler, Gregorio (Hospital La Vila, La Vila Joiosa); Dra. Sarmiento Guevara, Mónica (Hospital de la Santa Creu i Sant Pau, Barcelona); Dr. Todoli Parra, José Antonio (Hospital La Fe, Valencia); Dr. Tornero Ramos, Carmelo (Hospital Morales Meseguer, Murcia); Dr. Tovar Beltrán, Juan (Hospital Morales Meseguer, Murcia); Dra. Uceda Montañez, Julia Maria (Hospital de Valme, Sevilla); Dra. Vicente Rabaneda, Esther (Hospital La Princesa, Madrid). The authors also appreciate the collaboration of the participating patients and their families. Medical Writing support: TFS S.L.: Neus Valveny, PhD and Nerea Gallastegui, PhD.
Funding
This study was supported by Actelion Pharmaceuticals España, S.L. Medical writing assistance was provided by TFS S.L., with funding from Actelion Pharmaceuticals. Actelion did not have any role in the collection, analysis, and interpretation of data or writing the report. The views expressed are, therefore, based on author’s opinions and do not represent the views of Actelion or the journal.
Author information
Authors and Affiliations
Consortia
Contributions
IC contributed in desing, recruitting, statistical analysis, interpretation of results, discussion and final manuscript preparation. SE contributed to desing, recruiting, interpretation and final manuscript preparation. AE-C, JJR, JC-A, JLCR, CdlP, CPS, FJN, GE, PEC, MR-R, JJA, AG, JAR and VF contributed in recruitting, interpretation of results, discussion and final manuscript preparation. All co-authors take full responsibility for all parts of the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
IC have received speaker fees from Actelion, Roche, BMS and Pfizer. JJR and JJA have received educational grants from Actelion outside the submitted work. JJA has also received speaker fees from Actelion. SE has received a grant from Actelion for the work under consideration, and personal fees from Actelion and an educational grant from GlaxoSmithKline outside the submitted work. JAR has been board member for Roche, Actelion, Lilly, Gebro and MSD, and has received speaker fees from Roche, Abbvie, Lilly, BMS, UCB, Novartis, Pfizer, Celgene, FER and SVR, and travel grants from Janssen, Pfizer and Gebro. AE-C, JC-A, JLCR, CdlP, CPS, FJN, GE, PEC, MR-R, AGdC, and VF declare that they have no conflict of interest.
Ethical approval
All procedures performed were in accordance with the ethical standards of the national research committees of the participant institutions and with the 1964 Helsinki declaration and its later amendments.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Castellví, I., Eguiluz, S., Escudero-Contreras, A. et al. LAUDES Study: impact of digital ulcers on hand functional limitation, work productivity and daily activities, in systemic sclerosis patients. Rheumatol Int 39, 1875–1882 (2019). https://doi.org/10.1007/s00296-019-04436-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-019-04436-z